Implementation Support Strategies for Disruptive Behaviors
(SKIPforPA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests strategies to improve the use of a treatment for childhood disruptive behaviors and ADHD in pediatric primary care offices. The treatment, known as Doctor Office Collaborative Care (DOCC), has already shown positive results in managing these issues. The trial will compare different ways to implement DOCC, such as providing extra support to practice leaders or care teams, to determine the most effective approach. Caregivers of children aged 5-12 with noticeable behavior problems would be a good fit for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative strategies that could enhance care for children with behavioral challenges.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Doctor Office Collaborative Care (DOCC) safely manages childhood behavior issues and ADHD. Studies have found that DOCC results in a high number of children starting and completing treatment. Specifically, 99.4% of children began treatment, and 76.6% completed it, indicating the treatment's positive reception.
Moreover, DOCC has led to significant improvements in children's behavior and emotions, underscoring its effectiveness and safety. No major reports of negative side effects have emerged, making it a promising option for those considering participation in a clinical trial.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because they aim to enhance the implementation of DOCC, an evidence-based approach for managing disruptive behavior and ADHD. Unlike typical treatments that may lack structured support post-training, these strategies provide targeted support for practice leadership (LEAD) and care teams (TEAM), potentially increasing effectiveness. By providing tailored implementation support, these treatments might improve how DOCC is adopted and sustained in clinical settings, leading to better patient outcomes.
What evidence suggests that this trial's treatments could be effective for managing disruptive behavior and ADHD?
Research has shown that the Doctor Office Collaborative Care (DOCC) model effectively manages childhood behavior problems and ADHD. Studies have found that children are more likely to start and complete treatment with DOCC compared to regular care—99.4% start with DOCC versus 54.2% with usual care, and 76.6% complete treatment with DOCC versus 11.6% with usual care. DOCC also reduces oppositional behaviors and improves symptoms of oppositional defiant disorder (ODD) and overall quality of life over time. This model involves both the child and parent in behavioral therapy, a proven method for addressing disruptive behavior issues. The consistent improvements in clinical outcomes demonstrate DOCC's effectiveness in these areas. In this trial, participants will receive DOCC with varying levels of implementation support, including standard implementation, TEAM implementation, LEAD implementation, or both TEAM and LEAD implementation, to assess the impact of these support strategies on the effectiveness of DOCC.12567
Who Is on the Research Team?
David J Kolko, PhD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for caregivers with a child aged 5-12 showing behavior problems, and staff at selected pediatric practices in PA. Staff roles include primary care providers, care managers, medical directors/senior leaders, and practice managers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training
Standard training in the DOCC evidence-based practice (EBP) for all practices
Implementation
Implementation of DOCC with various support strategies (TEAM, LEAD, or both) delivered via videoconference
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- DOCC: Evidence-based treatment for disruptive behavior and ADHD
- Implementation support strategies at the leadership level following standard implementation of DOCC
- TEAM: Implementation support strategies at the care team level following standard implementation of DOCC
DOCC: Evidence-based treatment for disruptive behavior and ADHD is already approved in United States for the following indications:
- Disruptive behavior
- Attention-deficit/hyperactivity disorder (ADHD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
Pennsylvania American Academy of Pediatrics
Collaborator
NYU Langone Health
Collaborator
University of Michigan
Collaborator
Pennsylvania Chapter American Academy of Pediatrics
Collaborator
National Institute of Mental Health (NIMH)
Collaborator
American Academy of Pediatrics
Collaborator
Drexel University
Collaborator